Thompson J. NAFLD increases risk of all-cause mortality. Practitioner November/December 2021;265(1853):9

NAFLD increases risk of all-cause mortality

20 Dec 2021Registered users

In patients with non-alcoholic fatty liver disease (NAFLD), fibrosis stages F3 and F4 are associated with an increased risk of liver-related health problems and death from all causes, a large prospective study from the USA has found.

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.

To buy this article (£25+tax) copy the article citation above and click Buy article